Literature DB >> 28736647

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses.

Neil Vasan1, Maria Ignez Braghiroli2, Alexander N Shoushtari1,3, Richard Kinh Gian Do1,3, Marcia Edelweiss1,3, Ali Shamseddine3, Walid Faraj4, Deborah Mukherji4, Ali Haydar4, Ashwaq Olayan5, Fouad Sabatin5, Rita Assi4, Imane El Dika4, Leonard B Saltz1,3, Ghassan K Abou-Alfa1,3, Eileen M O'Reilly1,3.   

Abstract

Entities:  

Year:  2017        PMID： 28736647      PMCID： PMC5506282          DOI： 10.21037/jgo.2017.01.21

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  22 in total

1.  Improved overall survival in melanoma with combined dabrafenib and trametinib.

Authors:  Caroline Robert; Boguslawa Karaszewska; Jacob Schachter; Piotr Rutkowski; Andrzej Mackiewicz; Daniil Stroiakovski; Michael Lichinitser; Reinhard Dummer; Florent Grange; Laurent Mortier; Vanna Chiarion-Sileni; Kamil Drucis; Ivana Krajsova; Axel Hauschild; Paul Lorigan; Pascal Wolter; Georgina V Long; Keith Flaherty; Paul Nathan; Antoni Ribas; Anne-Marie Martin; Peng Sun; Wendy Crist; Jeff Legos; Stephen D Rubin; Shonda M Little; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.

Authors:  Emanuela Romano; Michael Scordo; Stephen W Dusza; Daniel G Coit; Paul B Chapman
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

3.  Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Authors:  P B Chapman; L H Einhorn; M L Meyers; S Saxman; A N Destro; K S Panageas; C B Begg; S S Agarwala; L M Schuchter; M S Ernstoff; A N Houghton; J M Kirkwood
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

4.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Authors:  Donavan T Cheng; Talia N Mitchell; Ahmet Zehir; Ronak H Shah; Ryma Benayed; Aijazuddin Syed; Raghu Chandramohan; Zhen Yu Liu; Helen H Won; Sasinya N Scott; A Rose Brannon; Catherine O'Reilly; Justyna Sadowska; Jacklyn Casanova; Angela Yannes; Jaclyn F Hechtman; Jinjuan Yao; Wei Song; Dara S Ross; Alifya Oultache; Snjezana Dogan; Laetitia Borsu; Meera Hameed; Khedoudja Nafa; Maria E Arcila; Marc Ladanyi; Michael F Berger
Journal:  J Mol Diagn       Date:  2015-03-20       Impact factor: 5.568

5.  Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.

Authors:  Giuliana Carlos; Rachael Anforth; Arthur Clements; Alexander M Menzies; Matteo S Carlino; Shaun Chou; Pablo Fernandez-Peñas
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

6.  High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.

Authors:  Maureen E Mork; Y Nancy You; Jun Ying; Sarah A Bannon; Patrick M Lynch; Miguel A Rodriguez-Bigas; Eduardo Vilar
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

Review 7.  Identifying people at a high risk of developing pancreatic cancer.

Authors:  Alison P Klein
Journal:  Nat Rev Cancer       Date:  2012-12-06       Impact factor: 60.716

8.  Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.

Authors:  Inmaculada de Juan Jiménez; Zaida García Casado; Sarai Palanca Suela; Eva Esteban Cardeñosa; José Antonio López Guerrero; Ángel Segura Huerta; Isabel Chirivella González; Ana Beatriz Sánchez Heras; Ma José Juan Fita; Isabel Tena García; Carmen Guillen Ponce; Eduardo Martínez de Dueñas; Ignacio Romero Noguera; Dolores Salas Trejo; Mercedes Goicoechea Sáez; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

9.  Endoscopic retrograde cholangiopancreatography (ERCP) in pancreatic disease: a reassessment of the specificity of ductal abnormalities indifferentiating benign from malignant disease.

Authors:  P W Ralls; J Halls; I Renner; H Juttner
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

10.  RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.

Authors:  Fei Su; Amaya Viros; Carla Milagre; Kerstin Trunzer; Gideon Bollag; Olivia Spleiss; Jorge S Reis-Filho; Xiangju Kong; Richard C Koya; Keith T Flaherty; Paul B Chapman; Min Jung Kim; Robert Hayward; Matthew Martin; Hong Yang; Qiongqing Wang; Holly Hilton; Julie S Hang; Johannes Noe; Maryou Lambros; Felipe Geyer; Nathalie Dhomen; Ion Niculescu-Duvaz; Alfonso Zambon; Dan Niculescu-Duvaz; Natasha Preece; Lídia Robert; Nicholas J Otte; Stephen Mok; Damien Kee; Yan Ma; Chao Zhang; Gaston Habets; Elizabeth A Burton; Bernice Wong; Hoa Nguyen; Mark Kockx; Luc Andries; Brian Lestini; Keith B Nolop; Richard J Lee; Andrew K Joe; James L Troy; Rene Gonzalez; Thomas E Hutson; Igor Puzanov; Bartosz Chmielowski; Caroline J Springer; Grant A McArthur; Jeffrey A Sosman; Roger S Lo; Antoni Ribas; Richard Marais
Journal:  N Engl J Med       Date:  2012-01-19       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.